Abrar A Anwar

StanChart signs $20m musharaka deal with Incepta Pharma

Incepta Pharmaceuticals Ltd signed a Musharaka deal worth US $ 20 million with Standard Chartered Bank, thus becoming the bank's Wholesale Banking Saadiq client. The money is a term finance for 5 years and will be used for Incepta Pharma expansion projects.

Syndicate content